EOC-103 (Palbociclib)

About EOC Pharma

EOC Pharma is a clinical-stage oncology company leveraging a targeted therapy approach to develop treatments for cancers with high unmet need. The company has advanced its lead asset into mid-stage clinical trials in China, positioning it to address a significant regional market. As a private entity, it operates with a capital-efficient model, combining US-based strategic direction with China-based clinical execution. Its success hinges on demonstrating clinical efficacy in its lead programs and securing further partnerships or funding for development.

Therapeutic Areas